“A vaccine has been patented by the Institute.
Gamaleya is a vaccine against strains of coronavirus "delta" and "omicron", TASS quotes Zubov.
On November 18, it became known that the first drug against COVID-19 based on monoclonal antibodies from AstraZeneca was registered in Russia.
An expert in laboratory diagnostics from Yekaterinburg, Alexander Solovyov, commented on the situation with the incidence of metapneumovirus.